Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer's disease, offering hope for slowing its progression. T ...

Western drugmakers are striking more deals in China to access “bio-better” treatments for diseases from obesity to cancer, ...

The Scottish Medicines Consortium announced lecanemab would not be made available on the NHS, following a similar decision ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

When it comes to investing in pharmaceutical companies, looking at pipelines and research and development prospects is ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...